-
?ECONOMIC IMPACT OF PET-18FLUTEMETAMOL GUIDED TREATMENT ALLOCATION IN THE DIAGNOSIS AND MANAGEMENT OF ALZHEIMER DISEASE. A BUDGET IMPACT MODEL FOR EUROPEAN PAYERS...
Mar 18, 2026, 21:38 PM -
DISPARITY IMPLICATIONS OF MACHINE-LEARNING-BASED MTM ELIGIBILITY CRITERIA
Mar 18, 2026, 21:38 PM -
VALIDATION OF A CLAIMS ALGORITHM TO IDENTIFY PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1 (DM1)
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF PREVENTING RECURRENT STROKE THROUGH OCCLUDER DEVICE SELECTION IN PATIENTS WITH PATENT FORAMEN OVALE: A PERSPECTIVE FROM US HOSPITALS
Mar 18, 2026, 21:38 PM -
PILOT EVALUATION OF AI-ENABLED AMBIENT SPEECH CAPTURE IN HOME-BASED CARE: REDUCING ADMINISTRATIVE BURDEN AND ENHANCING REAL-WORLD EVIDENCE GENERATION FOR COMPLEX THERAPIES
Mar 18, 2026, 21:38 PM -
AN AI-DRIVEN RANDOM SURVIVAL FOREST MODEL FOR PREDICTING CANCER-SPECIFIC SURVIVAL IN PEDIATRIC NEUROBLASTOMA: A SEER ANALYSIS
Mar 18, 2026, 21:38 PM -
A NOVEL MULTIVARIATE APPLICATION OF PROFILE ANALYSIS TO CHARACTERIZE MULTIDOMAIN PATIENT-REPORTED OUTCOME (PRO) PATTERNS IN PATIENTS WITH GASTRIC OR GASTROESOPHAGEAL JUNCTION (GC/GEJC) ADENOCARCINOMA
Mar 18, 2026, 21:38 PM -
IMPACT OF THE FDA DRUG SAFETY COMMUNICATIONONCODEINE ANDTRAMADOLPRESCRIBING INPEDIATRICDENTALCARE:EVIDENCE FROMNATIONALLY SOURCEDCLAIMSDATA
Mar 18, 2026, 21:38 PM -
TRENDS IN ATOPIC DERMATITIS MEDICATION UTILIZATION AND PHARMACY COSTS IN PEDIATRIC COMMERCIAL AND MEDICAID POPULATIONS
Mar 18, 2026, 21:38 PM -
PATIENT IDENTIFICATION FOR RARE DISEASES WITH RECENT ICD-10-CM DESIGNATION USING CLAIMS DATA
Mar 18, 2026, 21:38 PM -
DOES VULNERABILITY DRIVE UTILIZATION: ASSESSING DIFFERENTIAL HEALTHCARE UTILIZATION AMONG DUAL-ELIGIBLE VERSUS FEE-FOR-SERVICE MEDICARE BENEFICIARIES FROM EARLY TO MID-STAGE AD/ADRD/MCI
Mar 18, 2026, 21:38 PM -
CARDIOVASCULAR RISK AND COMORBIDITY BURDEN IN JAPANESE PATIENTS WITH MYASTHENIA GRAVIS A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
HOME NURSING CARE AND PATIENT SATISFACTION IN TRANSDANUBIA
Mar 18, 2026, 21:38 PM -
BURDEN OF SYMPTOMS IN TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A UNITED STATES PHYSICIAN SURVEY DESCRIBING GENDER PERSPECTIVES
Mar 18, 2026, 21:38 PM -
ELICITING CANCER PROGRESSION RATES FOR LOCALLY/REGIONAL RECURRENT (LR) POPULATIONS USING AGGREGATE LEVEL SURVIVAL DATA: AN ILLUSTRATION FROM MELANOMA
Mar 18, 2026, 21:38 PM -
CAN ARTIFICIAL INTELLIGENCE ASSISTED SYSTEMATIC LITERATURE REVIEW SUPPORT RIGOROUS EVIDENCE GENERATION? A CASE STUDY ON PREDICTORS OF COPD EXACERBATIONS
Mar 18, 2026, 21:38 PM -
INTEGRATING MEDICINES AND MEDICAL SERVICES IN REAL-WORLD VALUE ASSESSMENT: EVIDENCE FROM SUBCUTANEOUS ONCOLOGY FORMULATIONS IN A DAY CARE SETTING
Mar 18, 2026, 21:38 PM -
INTEGRATION OF ARTIFICIAL INTELLIGENCE IN REAL-WORLD CLINICAL PRACTICE AND EVIDENCE GENERATION: 2025 LANDSCAPE OF PHYSICIAN ADOPTION IN CHINA
Mar 18, 2026, 21:38 PM -
ESTIMATING HETEROGENEOUS TREATMENT EFFECTS FOR PHARMACOEPIDEMIOLOGIC STUDIES: A SCOPING REVIEW FOR CAUSAL FOREST MODELS
Mar 18, 2026, 21:38 PM -
MIND THE MORTALITY GAP: COMPARING AVERAGE AND AGE-DISTRIBUTION APPROACHES TO ESTIMATING BACKGROUND SURVIVAL FOR HEALTH ECONOMIC MODELS
Mar 18, 2026, 21:38 PM
